Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study

[1]  E. Brusina,et al.  Infectious Agents and Cancer , 2012, Springer Netherlands.

[2]  L. Bruni,et al.  Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report. , 2012, Vaccine.

[3]  O. Lavie,et al.  [Human papillomavirus types in women with cervical cancer in Haifa District]. , 2011, Harefuah.

[4]  Alan D. Lopez,et al.  Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.

[5]  F. Buonaguro,et al.  Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[6]  A. Ayhan,et al.  Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit , 2009, BMC infectious diseases.

[7]  M. Niakan,et al.  Human Papillomavirus (HPV) Detection in Biopsies from Cervical Cancer Patients; A Population–Based Study from Iran , 2009 .

[8]  F. X. Bosch,et al.  Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. , 2008, Vaccine.

[9]  H. Skomedal,et al.  Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas , 2006, Journal of Clinical Microbiology.

[10]  K. Shah,et al.  Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India , 2005, BMC infectious diseases.

[11]  B. Rose,et al.  Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. , 2004, Gynecologic oncology.

[12]  Xavier Castellsagué,et al.  Against which human papillomavirus types shall we vaccinate and screen? the international perspective , 2004, International journal of cancer.

[13]  U. Gyllensten,et al.  Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer , 2003, Journal of Clinical Microbiology.

[14]  H. Dienes,et al.  Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. , 2003, The American journal of pathology.

[15]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[16]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[17]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[18]  H. Dienes,et al.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas , 2001, Cancer.

[19]  A. Basarab,et al.  Detection of Cervical Infections in Colposcopy Clinic Patients , 2001, Journal of Clinical Microbiology.

[20]  E. Pirog,et al.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. , 2000, The American journal of pathology.

[21]  N. Muñoz,et al.  Human papillomavirus and cancer: the epidemiological evidence. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[22]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[23]  M. Sherman,et al.  Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia. , 1997, International journal of cancer.

[24]  P. Boffetta,et al.  Cancer in developing countries , 1994, CA: a cancer journal for clinicians.

[25]  J. Kaldor,et al.  The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain , 1992, International journal of cancer.

[26]  H. Goudarzi,et al.  PCR detection and high risk typing of human papillomavirus DNA in cervical cancer in Iranian women , 2008 .

[27]  Yongge Wu,et al.  HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. , 2007, Gynecologic oncology.

[28]  C. Woodman,et al.  The natural history of cervical HPV infection: unresolved issues , 2007, Nature Reviews Cancer.

[29]  J. Didziapetriene,et al.  [Investigation of human papillomavirus, its types and variants]. , 2005, Medicina.

[30]  M. Zali,et al.  The Prevalence of Human Papillomavirus in Cervical Cancer in Iran. , 2002, Asian Pacific journal of cancer prevention : APJCP.